These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
439 related articles for article (PubMed ID: 8723884)
1. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines. Ahern TE; Bird RC; Bird AE; Wolfe LG Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884 [TBL] [Abstract][Full Text] [Related]
2. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study. Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393 [TBL] [Abstract][Full Text] [Related]
3. Increased expression of C5a receptor (CD88) mRNA in canine mammary tumors. Hezmee MN; Kyaw-Tanner M; Lee JY; Shiels IA; Rolfe B; Woodruff T; Mills PC Vet Immunol Immunopathol; 2011 Jan; 139(1):50-6. PubMed ID: 20846729 [TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification. Ram TG; Ethier SP Cell Growth Differ; 1996 May; 7(5):551-61. PubMed ID: 8732665 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of the erbB-2 proto-oncogene in canine osteosarcoma cell lines and tumors. Flint AF; U'Ren L; Legare ME; Withrow SJ; Dernell W; Hanneman WH Vet Pathol; 2004 May; 41(3):291-6. PubMed ID: 15133183 [TBL] [Abstract][Full Text] [Related]
6. Derlin-1 and stanniocalcin-1 are differentially regulated in metastasizing canine mammary adenocarcinomas. Klopfleisch R; Gruber AD J Comp Pathol; 2009; 141(2-3):113-20. PubMed ID: 19515379 [TBL] [Abstract][Full Text] [Related]
7. Increased survival in dogs with malignant mammary tumours overexpressing HER-2 protein and detection of a silent single nucleotide polymorphism in the canine HER-2 gene. Hsu WL; Huang HM; Liao JW; Wong ML; Chang SC Vet J; 2009 Apr; 180(1):116-23. PubMed ID: 18061495 [TBL] [Abstract][Full Text] [Related]
8. HER-2 expression in canine morphologically normal, hyperplastic and neoplastic mammary tissues and its correlation with the clinical outcome. Ressel L; Puleio R; Loria GR; Vannozzi I; Millanta F; Caracappa S; Poli A Res Vet Sci; 2013 Apr; 94(2):299-305. PubMed ID: 23141215 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor and epidermal growth factor independence in human mammary carcinoma cells with c-erbB-2 gene amplification and progressively elevated levels of tyrosine-phosphorylated p185erbB-2. Ram TG; Dilts CA; Dziubinski ML; Pierce LJ; Ethier SP Mol Carcinog; 1996 Mar; 15(3):227-38. PubMed ID: 8597535 [TBL] [Abstract][Full Text] [Related]
10. Expression of growth hormone in canine mammary tissue and mammary tumors. Evidence for a potential autocrine/paracrine stimulatory loop. van Garderen E; de Wit M; Voorhout WF; Rutteman GR; Mol JA; Nederbragt H; Misdorp W Am J Pathol; 1997 Mar; 150(3):1037-47. PubMed ID: 9060840 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of caveolin-1 in normal and neoplastic canine mammary tissue. Amorim I; Lopes CC; Faustino AM; Pereira PD J Comp Pathol; 2010 Jul; 143(1):39-44. PubMed ID: 20153867 [TBL] [Abstract][Full Text] [Related]
12. Telomerase reverse transcriptase (TERT) expression in canine mammary tissues: a specific marker for malignancy? Zavlaris M; Angelopoulou K; Vlemmas I; Papaioannou N Anticancer Res; 2009 Jan; 29(1):319-25. PubMed ID: 19331168 [TBL] [Abstract][Full Text] [Related]
13. The combined expression pattern of BMP2, LTBP4, and DERL1 discriminates malignant from benign canine mammary tumors. Klopfleisch R; Klose P; Gruber AD Vet Pathol; 2010 May; 47(3):446-54. PubMed ID: 20375427 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence. Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038 [TBL] [Abstract][Full Text] [Related]
15. Mutation and overexpression of p53 as a prognostic factor in canine mammary tumors. Lee CH; Kim WH; Lim JH; Kang MS; Kim DY; Kweon OK J Vet Sci; 2004 Mar; 5(1):63-9. PubMed ID: 15028887 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of tissue factor expression in canine tumor cells. Stokol T; Daddona JL; Mubayed LS; Trimpert J; Kang S Am J Vet Res; 2011 Aug; 72(8):1097-106. PubMed ID: 21801068 [TBL] [Abstract][Full Text] [Related]
17. Expression of c-erbB-2 proto-oncogene in extrahepatic cholangiocarcinoma and its clinical significance. Zheng J; Zhu YM Hepatobiliary Pancreat Dis Int; 2007 Aug; 6(4):412-5. PubMed ID: 17690040 [TBL] [Abstract][Full Text] [Related]
18. Enhanced c-erbB-2/neu expression in human ovarian cancer cells correlates with more severe malignancy that can be suppressed by E1A. Yu D; Wolf JK; Scanlon M; Price JE; Hung MC Cancer Res; 1993 Feb; 53(4):891-8. PubMed ID: 8094034 [TBL] [Abstract][Full Text] [Related]
19. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer. Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Klopfleisch R; Gruber AD Vet Pathol; 2009 May; 46(3):416-22. PubMed ID: 19176491 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]